The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
about
Function-specific virtual screening for GPCR ligands using a combined scoring methodA full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptorsβ2-Adrenergic ion-channel coupled receptors as conformational motion detectorsImmobilised histidine tagged β2-adrenoceptor oriented by a diazonium salt reaction and its application in exploring drug-protein interaction using ephedrine and pseudoephedrine as probesG-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics SimulationAgonist-directed desensitization of the β2-adrenergic receptorThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsStereoselective activity of 2-(4-amino-3-chloro-5- trifluomethyl-phenyl)-2-tert-butylamino-ethanol hydrochloride to improve the pulmonary function in asthma.β-Adrenergic agonist and antagonist regulation of autophagy in HepG2 cells, primary mouse hepatocytes, and mouse liverIdentification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptorCardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices.Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area.Discovery of regulators of receptor internalization with high-throughput flow cytometry.Cardiovascular changes after administration of aerosolized salbutamol in horses: five cases.Are there functional β₃-adrenoceptors in the human heart?β2-adrenoceptor activation modulates skin wound healing processes to reduce scarringWhat can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.β-Blocker dialyzability and mortality in older patients receiving hemodialysis.Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.Gas phase ultraviolet and infrared spectroscopy on a partial peptide of β2-adrenoceptor SIVSF-NH2 by a laser desorption supersonic jet technique.Rapid analysis of interaction between six drugs and β2 -adrenergic receptor by injection amount-dependent method.Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.Single-molecule view of basal activity and activation mechanisms of the G protein-coupled receptor β2AR.Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor.β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.A Synergistic Antiobesity Effect by a Combination of Capsinoids and Cold Temperature Through Promoting Beige Adipocyte Biogenesis.Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region.Functional BK channels facilitate the β3-adrenoceptor agonist-mediated relaxation of nerve-evoked contractions in rat urinary bladder smooth muscle isolated strips.Construction of a cell model of β2-adrenoceptor downregulation.BRL37344, a β3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels.Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure.Lentivirus vector-mediated Rho guanine nucleotide dissociation inhibitor 2 induces beta-2 adrenergic receptor desensitization in β2AR desensitization mice model.Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts.β(3)-Adrenoceptor ligand development history through patent review.Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.Single-molecule analysis of ligand efficacy in β2AR-G-protein activation.β2 Agonists
P2860
Q28276613-38C8E83E-175C-4BE9-949C-BE1B920A337FQ28476391-359BD626-158D-4BBE-A82B-73BB65B46B2BQ28477521-0C2B51C0-8481-4F7A-ACF0-0D178040781CQ28538034-1989263F-37B4-49CB-A6EF-CC5A4180496DQ28552105-C4FD0180-6CDE-432F-B2CD-19EFBDC81B10Q28740731-B98E2D06-EEFE-4656-83A9-56A3B4845669Q30486707-D526520E-D577-4978-80D1-9FAD31526BB5Q33733512-42BC6CBF-149E-424D-8F5E-0EEAD16AFE18Q33783808-9A54BD39-0F25-40E0-827B-83703D7BC4FBQ34042126-0B53F335-A1A5-4678-8D1E-41DBDD9150CCQ34117883-C1233D68-5F9A-4F05-BA22-C44DC0F5C0DCQ34162794-C6EB9DE1-53BA-4A08-81BA-BF5F13D083CDQ34327895-028C06E3-347C-4134-A4D6-10CC3CCD596EQ34538228-2CE44308-D244-4C22-B452-5D4445F1D8DFQ34588651-CF417038-FE1D-4FE0-AFB4-96824108117CQ34680917-3EF0A763-77A9-4900-9CC6-45D3AC74F9C2Q34785448-844E8E31-5D0D-4BE4-A076-148D5653F99CQ34837191-EA42639F-5AC1-482E-8F9B-04C2C4C0D4A9Q35046547-9ECAEEF0-EA2D-4A1C-BCE7-F2E1E3AB3A55Q35228567-F598A825-D5B2-4914-BB50-F79C9D1E9AA4Q35687767-A4D592DE-FDE4-4A42-85FA-9B01BB22C42FQ36096970-0D71B264-B082-4E97-8445-6BB43CB11528Q36196650-171A38FD-E2B4-4FA9-BDA8-2F8C2EEBE54AQ36245570-3347709C-1E75-4759-8D87-BABEA67F855CQ36306077-E8346825-EBCD-46C8-810A-664D99628912Q36316813-CB5C6A7F-362B-4C4E-A25C-CB78C5D2A8F5Q36714097-8B627D43-30BC-478D-905B-DADE506D3CF9Q36820750-95C6C212-4276-405F-8461-88399160C237Q36855917-39C9719E-D53E-4196-80A5-E99E9447E808Q36920455-584707CB-E08E-4278-82A5-837EB41B6F6CQ37128059-100E8F7B-39B8-4659-8C17-D0BEE33794ECQ37136287-F49ABDA3-6187-438A-BF9F-DD2AFC0AFB85Q37416298-E07D8A7C-9E4F-47C0-963A-EF2E7C23BCD6Q37620533-B359C24F-26E1-484E-A975-1AFF93605C0CQ37670366-7AFD29C4-D0FE-4C91-B8D7-0FC1BA1D89E6Q37853580-6E8EDF8F-7606-406F-8917-3BA896300B81Q37978886-9FB871B7-8501-478D-891D-D3C7698761A7Q38641723-8910D0B6-5E7C-4942-A64F-30748E135FA6Q38728709-CADCDF67-EC5B-4446-B73D-F98B399704BAQ38791742-BC5AB338-75F1-42E9-B378-7A6C57F196CD
P2860
The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@en
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@nl
type
label
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@en
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@nl
prefLabel
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@en
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@nl
P2860
P1476
The selectivity of beta-adreno ...... eta2- and beta3-adrenoceptors.
@en
P2860
P304
P356
10.1111/J.1476-5381.2010.00754.X
P407
P577
2010-07-01T00:00:00Z